Suivre
Dr. Natarajan Ganesan
Dr. Natarajan Ganesan
Autres nomsG. Natarajan
Assistant Director of Research, New York Institute of Technology at Jonesboro, Arkansas
Adresse e-mail validée de georgetown.edu - Page d'accueil
Titre
Citée par
Citée par
Année
Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation
K Kitisin, N Ganesan, Y Tang, W Jogunoori, EA Volpe, SS Kim, V Katuri, ...
Oncogene 26 (50), 7103-7110, 2007
1502007
Gold layer-based dual crosslinking procedure of glucose oxidase with ferrocene monocarboxylic acid provides a stable biosensor
N Ganesan, AP Gadre, M Paranjape, JF Currie
Analytical biochemistry 343 (1), 188-191, 2005
882005
Increased DNA-binding activity of cis-1, 1-cyclobutanedicarboxylatodiammineplatinum (II)(carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell …
G Natarajan, R Malathi, E Holler
Biochemical pharmacology 58 (10), 1625-1629, 1999
661999
Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon
TG Natarajan, BV Kallakury, CE Sheehan, MB Bartlett, N Ganesan, ...
Cancer cell international 10, 1-12, 2010
602010
Markers in normal and cancer stem cells
TG Natarajan, KT FitzGerald
Cancer Biomarkers 3 (4-5), 211-231, 2007
472007
Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications
TG Natarajan, N Ganesan, KT FitzGerald
Cancer Biomarkers 9 (1-6), 65-99, 2011
222011
γ-Radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American Women: Caffeine modulates the outcome of mutagen sensitivity assay
TG Natarajan, N Ganesan, P Carter-Nolan, CA Tucker, PG Shields, ...
Cancer Epidemiology Biomarkers & Prevention 15 (3), 437-442, 2006
202006
Morphological and growth altering effects of Cisplatin in C. albicans using fluorescence microscopy
C Kesavan, M Raghunathan, N Ganesan
Annals of Clinical Microbiology and Antimicrobials 4, 1-4, 2005
162005
The strange case of BCG and COVID-19: the verdict is still up in the air
R Gopalaswamy, N Ganesan, K Velmurugan, V Aravindhan, S Subbian
Vaccines 8 (4), 612, 2020
132020
Helix–Coil Transitions in DNA Using a pH Variation Method: Case of a Melting Paradox as a Function of Ionic Strength
G Natarajan, R Malathi, E Holler
Analytical biochemistry 237 (1), 152-155, 1996
121996
Web-based interface facilitating sequence-to-structure analysis of BLAST alignment reports
N Ganesan, NF Bennett, M Velauthapillai, N Pattabiraman, R Squier, ...
Biotechniques 39 (2), 186-188, 2005
82005
Helix-coil transitions in DNA by novel Pt (II) complexes: a pH melting study
R Malathi, G Natarajan, E Holler
Journal of Biomolecular Structure and Dynamics 15 (6), 1173-1180, 1998
81998
TGF beta signaling in gastrointestinal stem cells
T Blake, N Ganesan, K Shetty, L Mishra
Sci STKE, 2005
32005
N-7-Alkyl-2′-Deoxyguanosine as surrogate biomarkers for N-nitrosamine exposure in human lung
N Ganesan, S Kato, ED Bowman, PG Shields
International journal of cancer prevention 2 (4), 265, 2007
22007
Smart antimicrobial coating with endless applications
A Tiwari, A Chaturvedi, N Ganesan
TechConnect Briefs 1, 236-239, 2018
1*2018
Phylogeny of conserved adenines in linkers of Group-I introns
N Ganesan, C Kesavan
Nature Precedings, 1-1, 2009
12009
BMP Signaling Pathway in Stem Cells
K Kitisin, N Ganesan, T Blake, N Golestaneh, N Katuri, T Saha, L Mishra
Sci. STKE (Connections Map), 2005
12005
Good-Bot Bad-Bot: Addressing bias in chatbots and public health information
N Ganesan, TG Natarajan
Available at SSRN 4520201, 2023
2023
Amplification of EGFR mutations, vIII and vIVa, in two patients with Esophageal Squamous Cell Carcinoma, hints at common binding targets.
N Ganesan, TG Natarajan
Authorea Preprints, 2023
2023
Will AI in Healthcare hasten the dystopian views seen in movies?
N Ganesan, T Govindan
Authorea Preprints, 2023
2023
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20